Clinical Trial Update: Study to Evaluate the Safety and Efficacy of the GGTA1 KO Thymokidney in Patients With ESRD [Phase 1, Phase 2]

View source ↗

Summary

This update describes an ongoing Phase 1/2 clinical trial evaluating the safety and efficacy of a GGTA1 knockout thymokidney for patients with end-stage renal d…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease
• Kidney Transplantation

Drugs mentioned

• GGTA1 KO thymokidney

Snippet

Sponsor: United Therapeutics | Conditions: ESRD (End-Stage Renal Disease), Kidney Transplantation | Phase 1, Phase 2 | Status: RECRUITING